Omar Dawood, M.D., MPH

Loading...
    • Media Contact:
      Rebecca Phillips
    • Member Type(s): Expert
    • Title:Vice President of Worldwide Clinical Development
    • Organization:Accuray Inc.
    • Area of Expertise:
    •  
    • Member:ProfNet

    To become a ProfNet premium member and receive requests from reporters looking for expert sources, click here.

My Expertise

    My Expertise

      Summary of expertise:
      Omar Dawood, M.D., MPH is vice president of Worldwide Clinical Development at Accuray Incorporated. Dr. Dawood can serve as an expert in the areas of stereotactic radiosurgery, radiation therapy, and innovative medical devices. After receiving his medical degree from Georgetown University, Dr. Dawood went on to residency training in surgery and radiology, and a fellowship in interventional radiology, at the University of California San Francisco. Dr. Dawoods abiding interest in cancer research, care and treatment began at age 15, when he was diagnosed with stage IV Hodgkins Lymphoma. He battled through surgical and chemotherapy treatments to become a cancer survivor. He brings this experience and passion for improving patient care to bear in his clinical development role at Accuray.
      Blog/Web site: www.accuray.com
      White paper/research:
      Dr. Dawood has conducted research in various topics most notably breast cancer risk factor profiling. In his role at Accuray, Dr. Dawood oversees clinical research programs worldwide that span numerous extracranial and intracranial clinical applications, including studies in lung cancer, prostate cancer, spine tumors and liver cancer.
      Books/articles published:
      Dawood, O, CyberKnife Treatment of Prostate Cancer: A Reply to Bentzen and Wasserman, 72 (1) International Journal of Radiation Oncology/Biology/Physics 14-18 (2008)

      Zheng T, Holford TR, Mayne ST, Tessari J, Ward B, Carter D, Owens PH, Boyle P, Dubrow R, Archibeque-Engle S, Dawood OR, Zahm SH, Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene, 9(2) Cancer Epidemiol Biomarkers Prev 167-74 (2000).

      DeBernardo RL, Aldinger CE, Dawood OR, Hanson RE, Lee SJ, Rinaldi SR, An E-mail assessment of undergraduates' attitudes toward smoking, 48(2) J Am Coll Health 61-6 (1999).

      Dawood, OR, Factors affecting body burden of organochlorine compounds, Scholarly Thesis (1998).

      Dawood, OR and Zheng, T, Risk of female breast cancer associated with organochlorines, 10th annual CACR, San Diego, CA (1998).

      Awards/associations/memberships:
      Dr. Dawood has been honored as both a Howard Hughes Scholar and National Cancer Institute Research Scholar.
      Prior media experience:
      National and international media including Washington Post, Health Imaging, The Gray Sheet, Kuwait Times, Silicon Valley Business Journal, San Francisco Chronicle, local San Francisco affiliates of ABC, CBS.
      Educational background:
      Dr. Dawood received his bachelors degree in analytical chemistry from the University of Pennsylvania and a Master of Public Health, concentrating on cancer epidemiology and health policy, from Yale University. He earned his medical degree from Georgetown University.

Profile TagsPlease separate tags with commas

  • Director, Online Community Relations
    ProfNet
    @profnet
    NJ
  • Community Editor
    ProfNet Connect (PR Newswire)
    @editorev
    NJ

Comments

Blog Headlines

    No recent blog posts
    Loading...